Skip to content

Optimizing accelerometer data analysis to assess physical activity and sedentary behavior among breast cancer survivors: a laboratory study

Optimizing accelerometer data analysis to assess physical activity and sedentary behavior among breast cancer survivors: a laboratory study - METRIC 2.0 validation study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43591
Enrollment
50
Registered
2016-08-04
Start date
2016-12-02
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer mammacarcinoma

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Female patients with histological confirmed primary breast cancer (with or without positive lymph nodes) stage I/II/III. aged > 18- 70 years, 2-4 months after completion of (neo-)adjuvant chemotherapy. Patients who receive (neo-) adjuvant chemotherapy for breast cancer are patients who are diagnosed with positive lymph nodes, or patients without positive lymph nodes but 1. aged 35 years (tumor 1.1 > cm) or 3. a Her2 positive tumor.

Exclusion criteria

Exclusion criteria: Male patients will be excluded from this study. Furthermore, patients who are not able to perform basic activities such as walking or biking, who show cognitive disorders or severe emotional instability, who are suffering from other disabling co-morbidity that might hamper physical exercise (e.g. heart failure, chronic obstructive pulmonary disease (COPD), orthopaedic conditions and neurological disorders), and patients who are unable to understand and read the Dutch language will be excluded from the study

Design outcomes

Primary

MeasureTime frame
Oxygen consumption during different activities

Secondary

MeasureTime frame
ActiTrainer accelerometer data ActivPAL inclinometer data Heart rate

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)